Assignee
EVECXIA THERAPEUTICS INC
US·3 granted patents·1 pending application·2 citations·filing 2022–2023
Top patents by PatentIndex Score
4 records- 0183US11779567B2Method for optimizing 5-hydroxytryptamine function in the brain for therapeutic purposesEVECXIA THERAPEUTICS INC·Filed 2022·Granted Oct 10, 2023·1 cites·22 claims
- 0282US11752107B25-hydroxytryptophan gastroretentive dosage formsEVECXIA THERAPEUTICS INC·Filed 2022·Granted Sep 12, 2023·1 cites·28 claims
- 0364US2024108582A15-hydroxytryptophan gastroretentive dosage formsEVECXIA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0457US12409163B2Method of enhancing 5-hydroxytryptophan (5-HTP) exposureEVECXIA THERAPEUTICS INC·Filed 2023·Granted Sep 9, 2025·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when EVECXIA THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →